| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
6e-14 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-12 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-12 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-12 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-11 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-11 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-11 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-11 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-10 |